Development of a UPLC-MS/MS method for the determination of lacosamide and its metabolite and its application to drug-drug interaction

Lacosamide, a third-generation novel antiepileptic drug, was first approved in 2008 as an adjunct to partial seizures. In 2014, the U.S. Food and Drug Administration (FDA) approved it as a single agent for partial seizures. Since epilepsy is a chronic condition, most patients need long-term antiepil...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Chen (Author), Yuxin Shen (Author), Hailun Xia (Author), Xiaohai Chen (Author), Ren-Ai Xu (Author), Guanyang Lin (Author), Gexin Dai (Author)
Format: Book
Published: Frontiers Media S.A., 2023-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available